PYRUVATE KINASE ACTIVATORS FOR USE IN TREATING BLOOD DISORDERS
申请人:Agios Pharmaceuticals, Inc.
公开号:US20200207785A1
公开(公告)日:2020-07-02
Described herein are compounds that activate pyruvate kinase, pharmaceutical compositions and methods of use thereof. These compounds are represented by Formula (I) wherein R
1
, R
2
, R
a
, R
b
, R
j
, R
k
, and Q are as defined herein